Michigan Law Review
Volume 69

Issue 6

1971

Torts--Strict Liability--A Hospital Is Strictly Liable for Transfusions
of Hepatitis-Infected Blood--Cunningham v. MacNeal Memorial

Hospital
Michigan Law Review

Follow this and additional works at: https://repository.law.umich.edu/mlr
Part of the Legal Remedies Commons, and the Torts Commons

Recommended Citation
Michigan Law Review, Torts--Strict Liability--A Hospital Is Strictly Liable for Transfusions of HepatitisInfected Blood--Cunningham v. MacNeal Memorial Hospital, 69 MICH. L. REV. 1172 (1971).
Available at: https://repository.law.umich.edu/mlr/vol69/iss6/7

This Note is brought to you for free and open access by the Michigan Law Review at University of Michigan Law
School Scholarship Repository. It has been accepted for inclusion in Michigan Law Review by an authorized editor
of University of Michigan Law School Scholarship Repository. For more information, please contact
mlaw.repository@umich.edu.

RECENT DEVELOPMENTS
TORTS-STRICT LIABILITY-A Hospital Is Strictly
Liable for Transfusions of Hepatitis-Infected
Blood-Cunningham v. MacNeal
Memorial Hospital*
While undergoing treatment at MacNeal Memorial Hospital
in Chicago, Illinois, Mrs. Frances Cunningham was given several
transfusions of whole blood. Apparently, some of the blood contained
the virus of homologous serum hepatitis1 because Mrs. Cunningham
was affiicted with that disease and forced to lengthen her stay in the
hospital. She sued the hospital for 50,000 dollars on the allegation
that the blood used in the transfusions "was defective and in an unreasonably dangerous condition." 2 The hospital defended on the
ground that Mrs. Cunningham's action was based on a theory of
strict liability inapposite to blood transfusion cases. The trial court
agreed and dismissed the complaint, but the appellate court reversed,
holding that blood is a product subject to the doctrine of strict
liability when sold.3 Significantly, however, the appellate court declined to determine whether the blood could have been made safe.~
Thus, the appellate court left open the issue whether the hospital
might escape liability if it could show that the blood was incapable
of being rendered safe. 5
• 47 Ill. 2d 443, 266 N.E.2d 897 (1970) [hereinafter principal case]. The appellate
court decision, reversing a judgment on the pleadings for the defendant, is reported
at 113 Ill. App. 2d 74, 251 N.E.2d 733 (1969).
I. Hepatitis is an inflammation of the liver. I ATIORNEY'S DICTIONARY OF MEDICINE
401 (1969). Homologous serum hepatitis is caused by a parenteral (through the blood
stream) introduction of a filterable agent known as virus B. Its effects can vary from
virtually none to severe illness and death. 2 R. GRAY, ATIORNEY'S TEXTBOOK OF MEDICINE ,i,i 38.30-.37 (3d ed. 1970); J. SCHMIDT, ATIORNEY's DICTIONARY OF MEDICINE
AND WORD FINDER 357 (1965); C. TABER, TABER'S CYCLOPEDIC MEDICAL DICTIONARY,
H-28 (9th ed. 1963). The condition is also known as serum hepatitis, homologous serum
jaundice, serum jaundice, inoculation jaundice, transfusion jaundice, post-vaccinal
hepatitis, post-vaccinal jaundice, and late arsphenamine jaundice. See J. SCHMIDT,
supra at 357; M. SPELLBERG, DISEASES OF THE LivER 256 (1954). Serum hepatitis is
clinically and pathologically indistinguishable from infectious hepatitis, but the latter
disease is contracted through the mouth and intestinal tract and has a shorter incubation period (10-40 days, as opposed to 45-160 days for serum hepatitis). M. SPELLBERG,
supra at 257. Serum hepatitis can also be transmitted by blood on any instrument that
pierces the skin. There are some recent indications that hepatitis may be spread by
direct and indirect contact as well as through transfusions and contaminated needles.
See N.Y. Times, Feb. 7, 1971, § I, at 70, cols. 3-4.
2. 113 Ill. App. 2d at 75-76, 251 N.E.2d at 733-34. The substantive portions of the
plaintiff's complaint are reproduced in the appellate court opinion.
3. 113 Ill. App. 2d at 85, 251 N.E.2d at 738.
4. Since the case was before the appellate court on appeal from a judgment on the
pleadings, the appellate court properly held that a decision on this question would have
been premature. 113 Ill. App. 2d at 86, 251 N.E.2d at 739.
5. The appellate court was apparently implying that a possible defense could be
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All such lingering doubts, however, were put to rest by the
Illinois supreme court. In an unprecedented decision based primarily
upon the Restatement (Second) of Torts section 402A,6 it agreed
with the appellate court that blood is a product and that a transfusion
is a sale within the meaning of the Restatement. But the supreme
court went further and announced that the "unavoidably unsafe"
exception of comment k 7 to the Restatement could not provide the
hospital with a valid defense. Comment k, according to the supreme
court," ... relates only to products which are not impure and which,
even if properly prepared, inherently involve substantial risk of
injury to the user.'' 8 Since hepatitis-infected blood is by definition
impure, comment k could have no bearing on the case. By reading
the comment so narrowly, the Illinois supreme court imposed strict
liability on hospitals for transfusions of blood carrying the serum
hepatitis virus. This Recent Development will briefly trace the development of hospital liability for transfusions of hepatitis-infected
blood and will analyze both the impact of Cunningham on that area
of the law and the correctness of the Cunningham decision.
raised based on RESTATEMENT (SECOND) OF TORTS § 402A, comment k at 353-54 (1965)
[hereinafter RESTATEMENT]. See note 7 infra for the full text of comment k.
6. Section 402A provides:
Special Liability of Seller of Product for Physical Harm to User or Consumer
(1) One who sells any product in a defective condition unreasonably dangerous to
the user or consumer or to his property is subject to liability for physical harm
thereby caused to the ultimate user or consumer, or to his property, if
(a) the seller is engaged in the business of selling such a product, and
(b) it is expected to and does reach the user or consumer without substantial
change in the condition in which it is sold.
(2) The rule stated in Subsection (1) applies although
(a) the seller has exercised all possible care in the preparation and sale of his
product, and
(b) the user or consumer has not bought the product from or entered into any
contractual relation with the seller.
RESTATEMENT § 402A, at 347-48 (emphasis added).
7. RESTATEMENT § 402A, comment k at 353-54 provides in full:
Unavoidably unsafe products. There are some products which, in the present state
of human knowledge, are quite incapable of being made safe for their intended
and ordinary use. These are especially common in the field of drugs. An outstanding example is the vaccine for the Pasteur treatment of rabies, which not
uncommonly leads to very serious and damaging consequences when it is injected.
Since the disease itself invariably leads to a dreadful death, both the marketing
and the use of the vaccine are fully justified, notwithstanding the unavoidable high
degree of risk which they involve. Such a product, properly prepared, and accompanied by proper directions and warning, is not defective, nor is it unreasonably
dangerous. The same is true of many other drugs, vaccines, and the like, many of
which for this very reason cannot legally be sold except to physicians, or under
the prescription of a physician. It is also true in particular of many new or experimental drugs as to which, because of lack of time and opportunity for sufficient
medical experience, there can be no assurance of safety, or even perhaps of purity
of ingredients, but such experience as there is justifies the marketing and use of
the drug notwithstanding a medically recognizable risk. The seller of such products,
again with the qualification that they are properly prepared and marketed, and
proper warning is given, where the situation calls for it, is not to be held to strict
liability for unfortunate consequences attending their use, merely because he has
undertaken to supply the public with an apparently useful and desirable product,
attended with a known but apparently reasonable risk.
8. 47
2d at 456, 266 N.E.2d at 904.

m.
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The disease that allegedly caused Mrs. Cunningham her anguish
has afflicted man for centuries,9 but not until the 1940's was it discovered that the causative virus could be introduced by the transfusion of blood.10 While hepatitis is not the only disease that can
be transmitted by blood transfusion,11 it does represent one of the
most serious risks associated with this treatment because of its frequency of occurrence,12 its undetectability, 13 and the present lack of
vaccines and other satisfactory methods of prevention.14
9. For a succinct history of serum hepatitis, see Butterich &: Wilson, Serum Hepatitis
-A Historical Perspective and Current Progress, 36 U. MICH. MED. CENTER J. 67 (1970)
10. See R. GRAY, supra note 1, ,r 38.35.
11. Other diseases that can be transmitted parenterally include malaria, syphilis,
measles, and influenza. See Wiener, Medicolegal Aspects of Blood Transfusions, 151
J.A.M.A. 1435, 1438 (1953). These diseases, however, do not pose the serious threat that
hepatitis does because they are readily detected when proper procedures are employed.
See Van Wormer, Blood Transfusion Therapy, Pitfalls and Practice, MED. TRIAL TECH.
Q., June, 1968, at 57-60.
12. Although there is agreement that the frequency of blood transfusions and the
incidence of serum hepatitis resulting therefrom are such that the disease presents a
very serious medical problem, the estimates demonstrate considerable divergence of
opinion on what the contractual rate actually is. Thus one encounters contentions rang•
ing from an infection rate of 3% in whole blood, R. GRAY, supra note I, ,r 38.35, to
one of .2%, Wiener, Prevention of Accidents in Blood Transfusions, 156 J.A.M.A. 1301,
1305 (1954). Others include .33%, 9 TRAUMATIC MEDICINE &: SURGERY FOR THE ATTORNEY
110 (1963); .25% to 3%, VanMeveren, The Extension of Liability to Service ContractsEmphasizing the Furnishing of Unfit Blood for Transfusion, 6 AM. Bus. L.J. 517, 518
(1968); and .1 to 1% "at most," Butterich &: Wilson, supra note 9, at 67. With the use
of blood plasma the rate jumps to around 12%, VanMeveren, supra at 518.
The hepatitis-related fatality figures similarly show a difference of opinion, with
some commentators asserting a rate of 3½% of those contacting the virus, Wiener,
supra note 11, at 1037. Others estimate 6%, 9 TRAUMATIC MEDICINE&: SURGERY FOR THE
ATTORNEY, supra at 110; and 12%, Chalmers, Koff &: Grady, A Note on Fatality in
Serum Hepatitis, 49 GASTRoENTEROLOGY 23 (1965). The last cited article is the most
complete study of the subject of those listed. In translating these percentages into numbers of patients affected one recent article summarized as follows:
Several studies on representative numbers of recipients of blood transfusions lead
to estimates of 30,000 cases of serious overt illness and 1,500 to 3,000 deaths from
transfusion-associated viral hepatitis [meaning in this instance serum hepatitis] each
year in the United States. However, there is evidence that the reporting of the
overt disease is incomplete and that the incidences of illness and mortality that it
causes may be much higher. Also, it is estimated that the ratio of subclinical hepatitis cases associated with transfusion to cases of the overt disease may be as high
as 5:1.
Panel of the Committee on Plasma and Plasma Substitutes of the Division of Medical
Sciences, Statement on Laboratory Screening Tests for Identifying Carriers of 'Viral
Hepatitis in Bloodbanking and Transfusion Services, IO TRANSFUSION 1-2 (1970) [here•
inaner TRANSFUSION].
All of the above statistics are, of course, subject to the limitations of the studies that
produced them, and this in part may explain the differences. Specifically, age of the
recipient, source of the blood, number of transfusions given, and procedures employed
by blood bank and hospital can and do significantly affect the findings. See generally
Chalmers, Koff &: Grady, supra.
13. See note 16 infra.
14. Mosely &: Galambos, 'Viral Hepatitis in DISEASES OF THE LivER 410 (L. Schiff 3d
ed. 1969) surmise at 468 that "[t]ransfusion-associated hepatitis, at least in relation
to whole blood and some blood products, cannot be eliminated." Furthermore, "[f]or
the foreseeable future ••• no vaccine is likely to be available against ••• serum hepa-
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Although there has been some literature heralding possible new
effective discovery procedures,15 the majority of professional sentiment concedes that at this point in time there exists no foolproof
analytical test or diagnosis that can identify the virus in a carrier.16
A carrier need never have contracted the disease,17 yet he can carry
the virus indefinitely18 and pass it to numerous recipients should he
habitually give blood. Moreover, despite some indications pointing
to the possibility of controlling the virus, 19 it is acknowledged that
there is no certain means of rendering the virus harmless or expunging it from the blood, plasma, or serum that is to be transfused.20
titis, •.. For serum hepatitis, active immunization of the general population may not
be feasible even if a vaccine is developed, because of numerous practical problems."

15. See generally TRANSFUSION, supra note 12; Bevan, Taswell 8e Gleich, Serum Immunoglobulin Leuels in Blood Donors Implicated in Transmission of Hepatitis, 203
J.A.M.A. 38 (1968); Garibaldi, A New Look at Hospitals' Liability for Hepatitis Contaminated Blood on Principles of Strict Tort Liability, 48 CHICAGO B. RECORD 206 (1967);
Weaver, King 8e Brown, A Clinical Evaluation of the "HIM" Test, 49 AM. J. CLINICAL
p ,\THOLOGY 647 (1968).
16, "Although many large efforts have been made to identify blood which has a
high risk of transmitting hepatitis, there is still no proved method for identifying the
hepatitis carriers." Walsh, Purcell, Morrow, Chanock 8e Schinidt, Posttransfusion Hepatitis After Open-Heart Operations, 211 J.A.M.A. 261, 265 (1970). This is not to say that
no carrier can be identified. Some demonstrate an overt illness that would call for im•
mediate disqualification, while others have abnormalities discoverable by means of liver
function tests. See Mosley 8e Galambos, supra note 14, at 420. Estimates of detection
rates range from 25 to 75%, Butterich 8e Wilson, supra note 9, at 70. One study states
that
the only laboratory screening test, currently available or proposed, that offers any
promise of useful application by blood-banking and transfusion services in identi•
fying the long-incubation [serum] form of hepatitis carriers is a test for the presence
of Australia antigen in blood.
Gocke 8e Kavey, Hepatitis Antigen, Correlation of Disease with Infectivity of Blood
Donors, 1 THE LANCET 1055 (1969). The same study points out that at the current
level of sensitivity, only about one-fourth of the cases can be detected by this means.
All agree that there exists no certain method of identifying contaminated individuals.
See, e.g., R. GRAY, supra note I, ,r 38.35; Mosley 8e Galambos, supra note 14, at 420;
Wiener, supra note 12, at 1305.
17, Mosley 8e Galambos, supra note 14, at 420; Wiener, supra note 12, at 1305.
18, Wiener, supra note 11, at 1438.
19, See, e.g., 279 NEW ENG, J. MED. 1290 (1968), where the director of a Red
Cross Blood Program stated preliminary results from a Massachusetts survey indicated
that by "packing" the red blood cells a much lower incidence of hepatitis was
achieved. Other factors cited as possible Initigating influences are storage at room temperatures over a period of several months and plasma irradiation. See R. GRAY, supra
note 1, ,r 38.35.
20. Butterich 8e Wilson, supra note 9, at 67 states:
[B]lood products have been used in large quantities only during the last 30 years
, • , [and] there has been a striking rise in the number of cases of serum hepatitis reported yearly. Unlike diseases which are becoming more prevalent for unknown
reasons, the increased incidence of serum hepatitis can be traced to epideiniologic
factors which we simply have been unable thus far to control.
Mosley 8e Galambos, supra note 14, at 429-30, further explains:
The repeated attempts to find processes for inactivating the viruses of hepatitis in
pooled plasma have been unavailing. Initially ultraviolet irradiation appeared to
be effective as judged by the results of human volunteer experiments. Subsequent
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Thus, although a hospital may be careful in its selection of donors
and meticulous in its methods of storage and administration, it is
still quite possible that a patient may contract hepatitis and perhaps
die if he has been injected with hepatitis-infected blood.
The lack of effective methods to discover and eliminate the
virus makes it difficult for plaintiffs to prove a failure by hospitals
to exercise reasonable diligence. Thus, attempts to hold hospitals
liable for transfusions of hepatitis-contaminated blood based on a
theory of negligence have been largely unsuccessful. 21 The same want
of preventive techniques renders a res ipsa loquitur assertion ineffective.22 A further obstacle encountered in some jurisdictions is
the rule that the doctrine of respondeat superior cannot be used to
hold a hospital liable for negligent harm inflicted by a physician or
medical employee while rendering professional services.28 Finally,
actions based on a theory of negligence per se24 or on the hospital's
experience .•• has demonstrated that plasma so treated, at least under conditions
of commercial porduction, still has a higher than average risk. Similarly, initial work
with storage for 6 months at "room" temperature, or under more carefully controlled conditions at 31.6° C (90° F), suggested that such material was safe, but a
carefully controlled prospective investigation showed that this process was also ineffective. Irradiated pooled plasma treated with betapropiolactone is reportedly
safe, but the study has not been confirmed and the material is commercially unavailable. No effective method for sterilizing fibrinogen or anti-hemophilic globulin
preparations is available.
21. See, e.g., Fischer v. Wilmington Gen. Hosp. 51 Del. 554, 149 A.2d 749 (1959);
Hiddy v. State, 207 Misc. 207, 137 N.Y.S.2d 334 (Ct. CI. 1955), afjd., 2 App. Div. 2d 644,
151 N.Y.S.2d 621 (1956); Parker v. State, 201 Misc. 416, 105 N.Y.S.2d 735 (Ct. Cl. 1951),
afjd., 280 App. Div. 157, 112 N.Y.S.2d 695, appeal denied, 280 App. Div. 901, 115
N.Y.S.2d 311 (1952).
22. Jackson v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd, on
other grounds, 53 N.J. 138, 249 A.2d 65 (1969). Since hepatitis can result from a blood
transfusion notwithstanding the hospital's diligent efforts to prevent it, the fact that a
patient contracted hepatitis is not sufficient to sustain the inference that someone was
negligent, a necessary element for reliance on a res ipsa loquitur theory. See "\V. PROSSER,
HANDBOOK OF THE LAw OF TORTS § 39, at 218-22 (3d ed. 1964).
23. See Becker v. City of New York, 2 N.Y.2d 226, 232-33, 140 N.E.2d 262, 266, 159
N.Y.S.2d 174, 180 (1957), in which the court stated:
•.• [Al hospital ••• [is] immune from liability predicated on the doctrine of
responaeat superior, when a patient at the hospital is injured as the result of a
medical act performed by an employee of the hospital in the course of treating the
patient•••. The rationale for ••• [this] is that the hospital employee when performing a medical act is an independent contractor to the patient•••• The theory
is that the hospital does not undertake to heal but merely to make healers available.
See also Capasso v. Square Sanitarium, Inc., 3 Misc. 2d 273, 155 N.Y.S.2d 313 (Sup. Ct.
1956); Lewis v. Columbus Hosp., 1 App. Div. 2d 444, 151 N.Y.S.2d 391 (1956). This rule,
however, does not apply in other jurisdictions. See, e.g., National Homeopathic Hosp,
v. Phillips, 181 F.2d 293 (D.C. Cir. 1950).
24. See, e.g., Merck & Co. v. Kidd, 242 F.2d 592 (6th Cir. 1957) (transfusion of hepatitis-contaminated blood not a sale of a "filthy substance" within the meaning of the
Tennessee Food, Drug and Cosmetic Act); Hoder v. Sayet, 196 S.2d 205 (Fla. Ct. App.
1967) (not negligence per se for a hospital to purchase or obtain blood from commercial
blood bank although such purchases may have increased the risk that the blood was
contaminated).
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failure to warn the patient of the dangers inherent in a transfusion25
have not been successful.
The lack of success in negligence suits prompted plaintiffs to
base their actions on theories of implied warranty26 and strict Iiability.27 However, a sale-service dichotomy that developed within the
implied warranty doctrine2 8 generally proved fatal to plaintiffs'
claims based on that theory.29 The sale-service dichotomy was first
used to defeat a claim for damages resulting from a transfusion of
hepatitis-infected blood in Perlmutter v. Beth David Hospital. 30
In that case, the defendant hospital had furnished blood for use
in a transfusion. Plaintiff contracted serum hepatitis and sued the
hospital for breach of implied warranty. Recovery was denied.
The New York Court of Appeals reasoned that the contract between
the plaintiff and the defendant hospital was essentially one for services. Moreover, the contract was not divisible even though it provided that the hospital should supply certain "healing materials"31
such as medicines, drugs, and even blood. The court concluded, therefore, that there was no sale to which an implied warranty could
attach.
Perlmutter has unquestionably been the most influential decision
in this area of the law. Although often criticized32 and recently re25. Sloneker v. St. Joseph's Hosp., 233 F. Supp. 105 (D. Colo. 1964); Fischer v.
Wilmington Gen. Hosp., 51 Del. 554, 149 A.2d 749 (1959).
26. For a discussion of the development of the implied warranty theory, see ·w.
PROSSER, supra note 22, § 97, at 678-81.
27. For a discussion of the theory of strict liability, see ·w. PROSSER, supra note 22,
§§ 74-79, at 506-44, § 87, at 672-85. It should be borne in mind that strict liability does
not mean absolute liability. Under the latter theory, causation and harm alone furnish
the basis for recovery. See Sweet v. State, 195 Misc. 494, 500-01, 89 N.Y.S.2d 506, 514
(Ct. CI. 1949). Under strict liability, which is not founded upon negligence, there is
still a dual requirement of (1) a defective product that is (2) unreasonably dangerous.
See, e.g., REsrATEMENT § 402A; Wade, Strict Tort Liability of Manufacturers, 19 Sw. L.J.
1, 13 (1965).
28. The sale-service dichotomy is one of the contractural rules associated with implied warranty that is criticized by W. PROSSER, supra note 22, § 95, at 655. Essentially,
the sale-service rule states that implied warranties can only attach to a contract for the
sale of products. Therefore, if the contract in any particular case is essentially one for
services, there is no implied warranty. For e.xamples of the application of this dichotomy in areas other than blood transfusion cases, see Consolidated Timber Co. v.
Womack, 132 F.2d 101 (9th Cir. 1942); Child's Dining Hall Co. v. Swingler, 173 Md.
490, 197 A. 105 (1938); Pappanastos v. State Tax Commn., 235 Ala. 50, 177 S. 158 (1937).
29. See cases cited in note 34 infra.
30. 308 N.Y. 100, 123 N.E.2d 792 (1954).
31. 308 N.Y. at 104, 123 N.E.2d at 794.
32. See, e.g., Boland, Strict Liability in Tort for Transfusing Contaminated Blood,
23 ARK. L. R.Ev. 236 (1969); Dunn, Blood Transfusions and Serum Hepatitis, 15 CLEV.MAR. L. R.Ev. 497 (1966); Haut &: Alter, Blood Transfusions-Strict Liability?, 43 ST.
JOHN'S L. R.Ev. 557 (1969); Comment, Serum Hepatitis Through Blood Transfusions: A
Wrong Without a Remedy?, 24 Sw. L.J. 305 (1970); Note, Warranties-Blood Transfusions-Extension of Implied Warranties, 38 FORDHAM L. REv. 830 (1970); Note, Sales-
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jected in a few cases,33 it has provided the foundation for decisions
in the majority of jurisdictions that have adjudicated the issue.H
The Cunningham decision, however, may signify an end to that
influence. The Illinois supreme court convincingly rejected the
holding in Perlmutter that a transfusion of blood is a service rather
than the sale of a product.35 Furthermore, since the Cunningham
court deemed blood contaminated with hepatitis an unreasonably
dangerous product,36 a patient contracting the disease by transfusion
or other injection may be virtually assured of success in a strict liability action against the hospital.37
Blood Transfusions-Implied Warranties Under the Uniform Commercial Code, 46
N.D. L. R.Ev. 367 (1970); Note, Blood Banks, Bad Blood, and Implied Warranty, 21
U. MIAMI L. R.Ev. 479 (1966); Note, Sale-Implied Warranty-No Warranty in Blood
Transfusion by Hospital, 37 NOTRE DAME LAW. 565 (1962); Note, Liability for Blood
Transfusion Injuries, 42 MINN. L. R.Ev. 640 (1958); Note, Action for Breach of Implied
Warranties of Quality Not Maintainable Against Hospital That Furnished Impure
Blood to Patient, 69 HARV. L. R.Ev. 391 (1955); Note, Warranty-Implied Warranties of
Quality Held Not Applicable to Blood Furnished by Hospital to Patient, 103 U. PA.
L. R.Ev. 833 (1955); Note, Sales-Breach of Warranty-Supplying of Blood by Hospital
Not a Sale, 29 ST. JoHN's L. R.Ev. 305 (1955).
33. See Hoffman v. Misericordia Hosp., 439 Pa. 501, 267 A.2d 867 (1970), in which
the court held that even if a transfusion could not be characterized as a "sale" the
plaintiff could still recover on the basis of breach of implied warranty. See also Jackson
v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd. on other grounds,
53 N.J. 138, 249 A.2d 65 (1969), in which the court held that a transfusion of human
blood for consideration was a sale. A few courts, while denying claims based on a
warranty running from the hospitals, have held that a warranty is properly assertable
against commercial blood banks. See, e.g., Carter v. Inter-Faith Hosp., 60 :Misc. 2d 733,
304 N.Y.S.2d 97 (Sup. Ct. 1969); Russell v. Community Blood Banlc, Inc., 185 S.2d 749
(Fla. Ct. App. 1966).
34. The following jurisdictions have indicated adherence to the Perlmutter rationale:
Arizona: Whitehurst v. American Natl. Red Cross, 1 Ariz. App. 326, 402 P.2d 584
(1965).
Colorado: Sloneker v. St. Joseph's Hosp., 233 F. Supp. 105 (D. Colo. 1964).
Connecticut: Epstein v. Giannattasio, 25 Conn. Supp. 109, 197 A.2d 842 (C.P. 1963)
(dictum).
Florida: White v. Sarasota County Pub. Hosp. Bd., 206 S.2d 19 (Fla. Ct. App. 1968).
But see Russell v. Community Blood Banlc, Inc., 185 S.2d 749 (Fla. Ct. App. 1966).
Georgia: Lovett v. Emory Univ., Inc., 116 Ga. App. 277, 156 S.E.2d 923 (1967).
Minnesota: Balkowitsch v. Minneapolis War Memorial Blood Banlc, Inc., 270 Minn.
151, 132 N.W.2d 805 (1965).
Texas: Goelz v. J.K. &: Susie L. Wadeley Research Institute, 350 S.W.2d 573
(Tex. Civ. App. 1961). (dictum).
Utah: Dibblee v. Dr. W. H. Groves Latter-Day Saints Hosp., 12 Utah 2d 241,
364 P.2d 1085 (1961).
Washington: Gile v. Kennewick Pub. Hosp. Dist., 48 Wash. 2d 774, 296 P.2d 662
(1956).
Wisconsin: Koenig v. Milwaukee Blood Center, Inc., 23 Wis. 2d 324, 127 N.W.2d
50 (1964).
35. 47 Ill. 2d at 451-52, 266 N.E.2d at 900-02.
36. 47 Ill. 2d at 456, 266 N.E.2d at 904.
37. The REsTATEMENT § 402A would impose liability for the sale of an unreasonably
dangerous product, and the court in Cunningham held that the transfusion of hepatitisinfected blood is such a sale. Assumption of risk remains a valid defense to an action
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The extent to which Cunningham will be accepted in other jurisdictions is difficult to determine. Although Perlmutter undoubtedly
continues to have considerable influence, Cunningham seems to be
in accord with the growing disenchantment of some courts with the
Perlmutter rationale 38 as well as with what some commentators have
been advocating for several years. 39 Moreover, several states still have
no statute or judicial ruling dealing with the issue,40 and Cunningham may well be influential in those states that are disposed toward
the view expressed in that case but are reluctant to effect the groundbreaking themselves.
On the other hand, several considerations tend to diminish the
impact that Cunningham may have in other jurisdictions. Twentythree states have enacted statutes that specifically preserve the "service" nature of blood transfusions.41 Since a sale is usually required
brought under strict liability. See REsTATEMENT § 402A, comment n at 356. Comment n
appears to limit the availability of the assumption of risk defense to cases in which
the plaintiff " ••• discovers the defect and is aware of the danger, and nevertheless
proceeds unreasonably to make use of the product." It is doubtful that a patient
who is informed of both the need for a blood transfusion and the possibility of
hepatitis virus in the blood to be used is acting unreasonably when he chooses to
undergo the transfusion.
38. See cases cited in note 33 supra.
39. See authorities cited in note 32 supra.
40. For states with a judicial ruling on point, see notes 33 & 34 supra. For states
that have a statute dealing with the issue, see note 41 infra.
41. See, e.g., CAL. HEALTH & SAFETY CODE § 1606 (West 1970), which provides:
The procurement, processing, distribution, or use of whole blood, plasma, blood
products, and blood derivatives for the purpose of injecting or transfusing the
same • • • into the human body shall be construed to be • • • the rendition of a
service by each and every person, firm, or corporation participating therein, and
shall not be construed to be ••• a sale ••• for any purpose or purposes whatsoever.
Other states that have enacted similar legislation include:
Alabama: ALA. CODE tit. 7A, § 2-314(4) (Supp. 1969).
Alaska: ALAsKA STAT. § 45.05.002 (1968).
Arizona: .ARIZ. R.Ev. STAT. ANN. § 36-1151 (Supp. 1970).
Arkansas: ARK. STAT. ANN. § 83-2-316(3)(d) (Supp. 1969).
Delaware: DEL. CoDE ANN. tit. 5A, § 2-316(5) (1971).
Louisiana: LA. Cxv. CODE ANN. art. 1764(B) (West Supp. 1968).
Maine: ME. R.Ev. STAT. ANN. tit. 11, § 2-108 (Supp. 1969).
Massachusetts: MAss. ANN. l.Aws ch. 106, § 2-316(5) (Supp. 1969).
Miclxigan: MICH. STAT. ANN. § 14.528(1) (Supp. 1969).
Mississippi: Miss. CoDE ANN. § 7129-71 (Supp. 1970).
Nebraska: NEB. R.Ev. STAT. § 7129-4001 (Supp. 1969).
Nevada: NEV. R.Ev. STAT. § 460.010 (1968).
New Mexico: N.M. STAT. ANN. § 12-12-5 (Supp. 1969).
North Dakota: N.D. CENT. CODE § 41-02-33(3)(d) (Supp. 1969).
Oklahoma: OKLA. STAT. ANN. tit. 63 § 2151 (Supp. 1970).
Oregon: ORE. R.Ev. STAT. § 97.300 (Supp. 1969).
South Carolina: S.C. CoDE ANN. § 32-559 (Supp. 1970).
South Dakota: S.D. CoMP. LAws ANN. § 57-4-33.1 (Supp. 1970).
Tennessee: TENN. CoDE ANN. § 47-2-316 (Supp. 1970).
Virginia: VA. CODE ANN. § 32-364.2 (1969).
Wisconsin: WIS. STAT. ANN. § 146.31(2) (Supp. 1970).
Wyoming: WYO. STAT. ANN. § 34-2-316(3)(d) (Supp. 1969).
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to bring strict liability into play,42 the effect of these statutes will be
to preclude any strict liability cause of action.43
In addition, the doctrine of sovereign immunity may exempt
publicly supported hospitals from the Cunningham approach in
many states.44 There are a great many exceptions to the sovereign
immunity rule, however, and it cannot be assumed that the existence
of the doctrine in any given state necessarily precludes recovery under
the Cunningham analysis. 45 Moreover, the courts have imposed a
variety of limitations upon the sovereign immunity doctrine.46
Furthermore, a court that is willing to accept the Cunningham analysis may also be willing to re-evaluate the doctrine of sovereign immunity and hold ,it inapplicable to blood transfusion cases.47 Yet
conceding all this, the fact that the doctrine of sovereign immunity
remains the law in over half of the states48 implies that the application of Cunningham will, in certain factual settings, thereby be
impeded.
A similar concept is the doctrine of charitable immunity, and
in those states where it is the law it too will hinder application of
a strict-liability theory to blood transfusion cases.49 Although the
trend is clearly in the direction of disapproval50 and limitation111
42. See note 6 supra.
43. But there will be no such elimination when there is no requirement of a sale.
See Hoffman v. Misericordia Hosp., 439 Pa. 501, 267 A.2d 867 (1970), discussed in note
33 supra.
44. For a discussion of sovereign immunity as a defense to tort claims, see
W. PROSSER, supra note 22, § 125, at 1001-03, § 127, at 1019.
45. For example, military, veterans, and public-service hospitals are subject to
suit under the Federal Tort Claims Act, 28 U.S.C. §§ 1291, 1346, 1402, 1504, 2110, 240102, 2411-12, 2671-80 (1964). The Act makes the United States liable for the wrongful acts or omissions of federal employees within the scope of their employment
"in the same manner and to the same extent as a private individual under like
circumstances" under the local law of the place where the tort occurs. 28 U.S.C. § 2674
(1964).
There are some instances, however, when the Federal Tort Claims Act is not
applicable-e.g., when the claim is based upon performance or failure to perform a
discretionary function, or when it is based upon an intentional tort, or an act or
omission of a governmental employee exercising due care in the execution of a statute
or regulation. Members of the armed forces cannot recover when the alleged injury was
incurred during active duty. See u. Prrrs. HEALTH LAW CENTER, PROBLEMS IN HOSPITAL
LAW 151-52 (1968) [hereinafter HEALTH LAW CENTER].
46. For example, the hospital may have to be engaged in a "governmental" function
as opposed to a "proprietary" one in order to qualify for the immunity. See generally
HEALTH LAW CENTER, supra note 45, at 152-54; W. PROSSER, supra note 22, § 125, at
1004-10.
47. For an example of such a judicial re-evaluation that resulted in a holding
that the doctrine does not protect public hospitals, see Muskopf v. Corning Hosp.
Dist., 55 Cal. 2d 211, 359 P.2d 457, 11 Cal. Rptr. 89 (1961).
48. I!EALTH LAW CENTER, supra note 45, at 152. An illustrative selection of cases is
listed in Annot., 25 A.L.R.2d 203 (1952).
49. For a discussion of the defense of charitable immunity to tort claims, see
W. PROSSER, supra note 22, § 127, at 1019-24.
50. "Where the question of [charitable immunity] has arisen as of first impression
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of charitable immunity, the doctrine continues to possess sufficient
vitality in some jurisdictions52 to thwart the assertion of a strict-liability argument against charitable entities.53
Perhaps the most significant of all the factors that will limit
the influence of Cunningham is the analytical fragility of the court's
reasoning. For though the court took a laudable step forward in
discarding the Perlmutter rationale, in doing so it brushed aside
a powerful objection to the application of strict liability with very
questionable commentary. The basic objection to holding hospitals
strictly liable for transfusions of hepatitis-infected blood is based on
comment k to section 402A of the Restatement of Torts. Comment k
excepts "unavoidably unsafe products" from the rule of strict liability. In order for a product to be unavoidably unsafe, three requirements must be met: (I) all reasonable efforts must be made to
make the product safe; (2) proper warnings of possible danger must
be given; (3) experience must justify the marketing of the product
despite the risk involved.54 The court added a fourth requirement,
however: the product must not be impure.55 Since hepatitis-infected
blood is by definition impure, the court held that it did not fall
within the comment k exception.
It is extremely difficult to justify the court's decision to read this
additional requirement into comment k. Indeed, the language of
comment k standing alone seems to refute thoroughly the court's
analysis:
... [A] product properly prepared, and accompanied by .proper
directions and warning, is not defective, nor is it unreasonably dangerous ... [when], because of lack of time and opportunity for
sufficient medical experience, there can be no assurance of safety,
or even perhaps of purity of ingredients, but such experience as
there is justifies the marketing and use of the . . . [product] notwithstanding a medically recognizable risk.56
within recent years, it has been uniformly rejected; in no jurisdiction has the doctrine
been adopted by overruling a prior judicial decision recognizing full liability."
HEALm LAw CENTER, supra note 45, at 149. See also C. KRAMER, MEDICAL MALPRACTICE
21-27 (rev. ed. 1965). W. PROSSER, supra note 22, § 127, at 1024, states that the doctrine
"is clearly in full retreat."
51. Even where the doctrine still exists, its vitality is often circumscribed by
limitations placed upon it. See generally HEALTH LAw CENTER, supra note 45, at 143-48.
52. For a jurisdiction-by-jurisdiction discussion of immunity rules and decisions, see
Annot., 25 A.L.R.2d 29, 142-200 (1952).
53. The determination whether a hospital can be characterized as charitable is
occasionally troublesome. No perfect definition can be framed. See Annot., 7 A.L.R.3d
1281, 1283 (1966).
54. REsTATEMENT § 402A, comment k at 354.
55. 47 lli. 2d at 456, 266 N.E.2d at 904.
56. REsTATEMENT § 402A, comment k at 353-54 (former emphasis original, latter
emphasis added).
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Thus, comment k specifically applies to the situation in which medical
knowledge cannot assure purity of ingredients but the use of the
product is justified nonetheless. Notably, the court omitted the portion relating to purity of ingredients from its quotation of comment
k.51
Moreover, the comment cites the Pasteur vaccine as an example
of a product to which strict liability should not attach. The court
distinguished the Pasteur vaccine from hepatitis-infected blood
on the ground that the latter is an impure substance while the former
is a pure substance. This distinction is factually questionable. The
Pasteur vaccine is cultured in the brains of small laboratory animals
such as rats, mice, and rabbits. Small particles of brain material
are left in the vaccine and it is this brain material that causes harm
to recipients of the vaccine.58 Thus, the Pasteur vaccine is not a
"pure" substance; it contains particles of foreign material that occasionally cause seric;ms harm to the recipient just as does hepatitisinfected blood. This fact supports the conclusion that the court was
engaged in a mere semantic exercise when it created the "pureimpure" distinction. And in so doing, the court distorted the thrust
of comment k. Comment k was intended to prevent the imposition
of strict liablility when the value of a medical product outweighs
its potential for causing harm by such a substantial degree that the
use of the product is justified.59 Therefore, in deciding whether
the comment is applicable in any given situation, a court should
determine only whether all reasonable efforts have been made to
make the product safe and whether the necessity of administering
the product outweighs an unavoidable element of risk to the patient.
The fact that all medical efforts to remove the hepatitis virus from
the blood have thus far been unsuccessful has already been documented. 60 And the necessity of blood transfusions in modern medicine
appears to be substantially on a par with that of the Pasteur vaccine. 61 Therefore, it seems clear that the court erred in adding the
57. 47 Ill. 2d at 456, 266 N.E.2d at 903-04.
58. "All these vaccines [various rabies vaccines including the Pasteur vaccine] suffer
from the presence of a large amount of foreign brain material which is capable of
producing encephalitis and paralysis in a certain small proportion of individuals
(1:4000 to 1:10,000)." Maccallum, Rabies, in VIRUS AND R.lCKEITSIAL DISEASFS OF MAN
253, 261 (4th ed. 1967).
59. See RESTATEMENT § 402A, comment k at 353-54, which justifies use of the Pasteur
vaccine despite the great risk involved.
60. See notes 15-20 supra and accompanying text.
61. "The development of the modern blood transfusion in the past half-century is
recognized by the medical profession as one of its finest achievements. Without today's
blood transfusions many of the modern surgical practices would not be possible, and
hemorrage would be a far greater cause of death." Note, 42 MINN. L. REV. 640, supra
note 32. See also Trout, Blood Transfusions, 73 DICK. L. REv. 201, 212 (1969).
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requirement that a product must be pure in order for comment k
to apply.62
The application of strict liability in any given situation has always rested heavily upon public-policy considerations. Although
the court in Cunningham erroneously distinguished comment k,
it was presumably free to reject the comment outright if it found
sufficiently compelling reasons to do so. Therefore, an examination
of the policy behind the application of strict liability to blood transfusion cases is required before any conclusions can be reached concerning the appropriateness of that doctrine for such cases.
Several commentators have argued that comment k should not
except contaminated-blood cases from the scope of Restatement section 402A.63 The proposition most often asserted is that the financial
consquences of a transfusion that results in hepatitis should be borne
by hospitals because they are in the best position to insure themselves against the loss. Insurance premium costs could then be absorbed into the general overhead costs of the health centers. In this
manner, the cost of a transfusion would be spread to all those who
avail themselves of the hospitals' services in the form of higher
hospital costs.64 Additionally, it has been argued that the imposition
62. For a case agreeing that comment k applies to transfusions of impure blood,
see Jackson v. Muhlenberg Hosp., 96 N.J. Super. 314, 232 A.2d 879 (L. 1967), revd. on
other grounds, 53 N.J. 138, 249 A.2d 65 (1969). See also Note, Liability of a Hospital
for,Supplying Unpure Blood, 1965 WIS. L. R.Ev. 374, 387-88.
63. See, e.g., Comment, Serum Hepatitis Through Blood Transfusions: A Wrong
Without a Remedy?, 24 Sw. L.J. 305 (1970); Comment, Strict Liability in Tort for
Transfusing Contaminated Blood, 23 ARK. L. R.Ev. 236 (1969).
64. Comment, 24 Sw. L.J. 305, supra note 63, at 321-25; Comment, 23 ARK. L. R.Ev.
236, supra note 63, at 245-49. This is the loss-spreading system imposed in effect by
Cunningham. It should be added that a secondary loss-spreading will occur among those
people who have medical insurance. The rise in hospital costs would be followed by a
rise in premium rates for medical insurance. However, it is difficult to rely on private
medical insurance as a loss-spreading device because many person are simply not
covered, often because of their financial status. J. BowER, E. CONNORS, J. MOSHER &: C.
ROWLEY, HOSPITAL INCOME FLOW-A STUDY OF THE EFFECTS OF SOURCE OF PAYMENT ON
HOSPITAL INCOME 48 (1970) [hereinafter HOSPITAL INCOME], demonstrate that payments
from uninsured individuals account for approximately 15% of the payments received by
hospitals from patients. This estimate was supported in an interview with John
Zurgich, Associate Director of University Hospital, The University of Michigan, in
Ann Arbor, Michigan, March 19, 1971 [hereinafter Zurgich Interview].
Moreover, even for the majority of patients who do have some type of protection,
the coverage is often far from adequate. See, e.g., S. GREENBURG, THE TROUBLED CALLING
132 (1965), in which the author states:
fllnsurance pays 40 percent of the cost of surgery, 30 percent of the expenditures
for the services of obstetricians, less than 10 percent of physicians' out of hospital
fees, and little or nothing for other services and supplies. This means that in the
course of a year, patients have to pay out of pocket an additional $2.5 billion for
hospitalization, $3.5 billion for doctors' services, $3.9 billion for drugs and $4.5
billion for other health services, such as dental care, nursing-home care, and appliances •••• While medical costs have been going up at the rate of 5 to 10 percent
a year, the ratio of such costs met by insurance has shown an average annual increase of less than 2 percent. At the same time, insurance premium charges have
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of strict liability would encourage a more rapid discovery of a cure
for hepatitis or a means of detecting the virus in blood. 65
The role of tort law as a loss distributor has grown dramatically
in recent years. 66 In light of this development, it would seem anomalous to allow a single, unfortunate patient to bear the costs that
result from a treatment-a blood transfusion-to which all persons
might be subjected. However, before the legal system imposes risk
allocation in blood transfusion cases, several questions should be
considered. How is this allocation to be achieved? Who should be
included within it? Is the tort law the most effective medium for
reaching the desired result? The decision in Cunningham can be
used as a tool of analysis in answering these questions.
As noted above, the result in Cunningham does effect some risk
allocation. 67 The court failed to point out, however, the severe
drawbacks that this type of risk allocation entails. Of necessity, the
hospitals' losses from some patients' contraction of post-transfusion
hepatitis will be defrayed by increased assessments on all their patients. 68 This is true because, unlike most manufacturers and sellers
who bear this type of business expense, health centers are not able
to modify the blood's characteristics or abstain from selling it altogether when the related financial responsibility becomes so onerous
as to make its sale unprofitable. 69 Similarly, the losses suffered by
commercial blood banks will be passed on primarily to hospital
patients and others in need of blood.70
been climbing "during the past decade at the rate of 10 percent a year under the
impact of rising medical costs and increased utilization.
Similarly, F. COOK, THE PLOT AGAINST THE PATIENT 231 (1967), notes that voluntary
insurance has come to a "virtual dead end. • • • After nearly 40 years of trial, the
only epitaph that can be written for the . • • program is that it is in no aspect
satisfactory or even adequate."
65. Comment, 24 Sw. L.J. 305, supra note 63, at 325; Comment, 23 ARK. L. REY.
236, supra note 63, at 249.
66. See generally J. FLEMING, AN INTRODUCTION TO THE LAW OF TORTS 1-24 (1967);
Prosser, The Fall of the Citadel (Strict Liability to the Consumer), 50 MINN. L. REY.
791 (1966).
67. See note 64 supra and accompanying text.
68. Predict Higher Patient Charges If Blood ls Treated as a Product, MODERN
HosP., Nov. 1970, at 34.
69. Once a hospital undertakes the care of a patient, of course, it might often be
under a duty to give the patient blood, and the failure to do so would clearly give rise to
an action based on negligence. See Church v. Adler, 350 Ill. App. 471, 113 N.E.2d 327
(1953); Skeels v. Davidson, 18 Wash. 2d 358, 139 P .2d 301 (1943).
70. Interview with Dr. Harold A. Oberman, Professor of Pathology and Medical
Director of the Blood Bank, University of Michigan Medical School, Ann Arbor,
Michigan, April 15, 1971 [hereinafter Oberman Interview]. Most hospitals purchase the
majority of their blood supply from various types of blood banks. See generally
CoMMI'ITEE ON PUBLIC HEALTfI, HUMAN BLOOD IN NEW YORK CITY-A STUDY IN !TS
PROCUREMENT, DISTRIBUTION AND UTILIZATION (1958). Therefore, increased costs resulting
from the imposition of strict liability on blood banks will be passed on to patients
through the hospitals when the blood is resold.
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The precise economic impact of this type of loss-spreading is
not entirely clear. In some cases the cost of blood alone will be
affected, but it seems probable that in many others the increased
costs will be allocated among all medical services provided by the
hospital. 71 If this is the case, the resulting increase in already
rapidly rising medical costs72 could be very substantial.73 Furthermore, if the Cunningham theory of strict liability in blood transfusion cases were to be applied to analogous situations such as organ
transplants, 74 the economic impact would be even more severe. And
as medical costs rise, health care will be placed further beyond the
reach of those persons in lower income brackets.
This economic burden on the poor is also a factor that distinguishes the strict liability imposed in Cunningham from that imposed by the courts in other product liability cases. An increase
71. Higher blood prices resulting from an imposition of liability on commercial
blood banks will often be reflected only in the price of blood. At the University of
Michigan Hospital, for example, it was estimated that the increased cost of blood
derived from external sources would be reflected solely in the price charged for blood.
On the other hand, if the hospital itself were held liable for hepatitis infection resulting from its own blood supply, those costs would be distributed among all products
and services sold by the hospital. Moreover, some private insurers are considering the
cancellation of hospital liability insurance entirely, apparently because of the unpredictable possibility of large recoveries. Should this happen, many hospitals and their
patients might face an even more serious economic problem. Oberman Interview, supra
note 70.
72. See Presidential Prescription for Health, TIME, March 1, 1971, at 11, in which
it is stated that since 1960 the average daily cost of hospitalization has risen from
$56 to $144. The nation's total health bill has reached $70 billion, more than double
that of a decade ago. This now averages $324 per person per year. See also Walsh,
Medical Care: As Costs Soar, Support Grows for Major Reform, 166 SCIENCE 1126 (1969);
Crisis Ahead in Medical Care, U.S. NEWS & WoRLD REP., Feb. 26, 1968, at 56; The
$60-Billion Crisis over Medical Care, BUSINESS WEEK, Jan. 17, 1970, at 50.
73. There can be no precise estimate of the increase in medical cost resulting from
the imposition of liability for transfusing a vitiated serum. However, since "[s]ome 2.5
million hospital patients are transfused annually," F. CooK, supra note 64, at 157,
and the incidence of infection may be around 3%, with 30,000 serious cases and up to
3,000 deaths per year (see note 12 supra), the recoveries could well be enough to increase
significantly the costs of hospitalization. This is particularly true in light of the fact
that awards may well exceed the $50,000 asked for by Mrs. Cunningham in the principal
case. With this in mind, it has been predicted that for a 400-bed hospital an average
$14 per patient-per day increase would result from the holding in Cunningham. See
MODERN HosP., supra note 68, at 35. Since hospital income is based primarily on
the number of patient-days it has (Zurgich Interview, supra note 64) the smaller
hospitals would experience even larger increases, and notably there is less patient insurance coverage in the rural health centers that have fewer beds than do other centers.
See HOSPITAL INCOME, supra note 64, at 25.
One concrete example of how Cunningham has affected blood-drawing institutions
can be seen in the rise in insurance rates for a Chicago area blood bank, which experienced a twenty-fold increase in annual premiums ($1,500 to $30,000) following the
decision. Letter from Nathan Smith, Executive Director of the Midwest Chapter of
the National Hemophilia Foundation, to Richard French, of Howard & French,
Chicago, Ill., Feb. 23, 1971. This increased insurance premium will almost certainly
be reflected in an increased cost of blood coming from the Chicago area blood banks.
74. See notes 80-82 infra and accompanying text.
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in the cost of automobiles, candy bars, or even canned meat that
results from the imposition of strict liability on the manufacturer
of these items does not have the effect of making a necessity of life
less available to financially disadvantaged persons. It is submitted
that the inability of hospitals to prevent the occurrence of hepatitis
coupled with this potential economic impact on the poor renders
application of strict liability in tort far less appropriate when
hepatitis-infected blood is sold than when ordinary consumer goods
are sold. The most desirable result would be to alleviate a recipient's
financial burden without substantially increasing the costs of medical
care in general. The most obvious way to achieve this result would
be to distribute the expenses associated with transfusion-contracted
hepatitis among the population as a whole. Since everyone is susceptible to disease and accident, and, correspondingly, the necessity
of receiving blood, it is not a harsh result to expect all persons to
bear a portion of the expense. The imposition of strict liability
on hospitals will spread the costs primarily to the purchasers of
hospitalization rather than to the public at large and therefore cannot achieve this result. 75
Another drawback to the Cunningham method of risk allocation
is that recovery is predicated upon litigation, or at least the threat
of litigation, against the hospital. This procedure inevitably suffers
from the economic disadvantages that attorney and court fees diminish a plaintiff's recovery and insurance company profits increase
the costs of providing the protection.76 Moreover, since the poor are
generally less aware of their rights and less able to litigate,77 they
are the least likely to be compensated for their losses. Additionally,
as noted above, several states continue to hold some hospitals free
from tort liability on the grounds of sovereign and charitable immunity. 78 In these states, some patients-again often the most needy
-will be left without a remedy if the hospital provides its own blood
supply.79 Thus by raising medical costs and implementing a system
75. See notes 70-73 supra and accompanying text. It should be noted that some
secondary loss-spreading among persons other than purchasers of hospitalization is
inevitable. For example, medical insurance rates will probably increase as the cost of
medical products rises; hence all policy holders will be affected whether or not they actually go to the hospital. Some insurance costs may, in turn, be passed on to the
customers of those who purchase the insurance. This secondary loss-spreading, however,
is extremely speculative and difficult to measure, and in any event will not be complete
loss-spreading since the burden will not fall equally on all people.
76. With respect to some of the obstacles in seeking judicially-imposed solutions in
today's courts, see What's Wrong with the Courts: The Chief Justice Speaks Out,
U.S. NEWS & WORLD REP., Aug. 24, 1970, at 68.
77. See generally Note, Litigation Costs: The Hidden Barrier to the Indigent, 56
GEO. L.J. 516 (1968).
78. See notes 44-53 supra and accompanying text.
79. If the blood is supplied by a commercial blood bank, however, charitable and
sovereign immunity would not bar an action against the blood bank. See note !Ill supra.
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of risk allocation that will be least accessible to the poor, Cunningham gives the least protection to those persons who need it most.
Furthermore, Cunningham may have ramifications in areas of
medicine other than the transfusion of blood. For example, if a
hospital were to have a patient badly in need of a kidney transplant
and the kidney used in the transplant was undetectably diseased,
the hospital might well be liable to the patient for any resulting
harm. 80 This would be so notwithstanding the fact that the hospital
was providing the best possible treatment and the patient's life was
extended several years as a result of the operation. Since in many
instances the organs capable of being transplanted have grossly undetectable deficiencies,81 the extension of strict liability to such situations could have the dual effect of further raising hospital costs and
reducing the available supply of transplant organs.82 Indeed, the
Cunningham analysis could be applied to medicines, anesthetics, and
practically any curative implement containing a hidden defect that
can be classified as an impurity.
Finally, the hastening of medical triumphs is not a necessary
or even probable consequence of the Cunningham result. Although
product safety is without doubt a result toward which the imposition of strict liability is directed,83 the influence of such liability is
questionable when the item sold is virtually unimprovable due to
the lack of requisite information and techniques. It seems quite
unlikely that the growth of medical knowledge will be quickened
by making hospitals guarantors of the purity of substances not yet
fully understood. Medical science seems to be making ample progress without the imposition of artificial economic stimuli.84 And
there is evidence that the Cunningham result will promote the
80. Other areas of transplants that could conceivably be affected include removable
and built-in prostheses and artificial organs, as well as homotransplants (from either
living humans or cadavers) and heterotransplants (from animal to man), Mouzas, The
Present State of Organ Transplantation, 46 INTI.. SURGERY 370 (1966); and the thymus,
Transplanting the Thymus, 2 THE LANCET 1226 (1968).
81. Oberman Interview, supra note 70.
82. It is quite likely that hospitals, wary of being held liable for hepatitis and
related injurious elements or defects, would establish certain rules or guidelines that
would tend to make blood and other materials less readily available. Zurgich Interview,
supra note 64.
83. See Escola v. Coca Cola Bottling Co., 24 Cal. 2d 453, 462, 150 P .2d 436, 440-41
(1944) Gustice Tra}nor, concurring):
Public policy demands that responsibility be fixed wherever it will most
effectively reduce the hazards to life and health inherent in defective products
that reach the market•••• It is to the public's interest to discourage the marketing
of products having defects.
84. See, e.g., The Wall St. J., March 2, 1971, at 23, col. 1 (midwest ed.), which reports
several of the efforts of individual researchers and such organizations as the National
Research Council, the Division of Biologics Standards of the National Institutes of
Health, the American Red Cross, and the American Association of Blood Banks.
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spending of funds by medical groups to effect the legislative repeal
of that case rather than to find a cure for hepatitis.85
None of the above drawbacks were discussed or even mentioned
by the court in Cunningham. The court seemed to assume that its
decision to impose strict liability on hospitals would yield a socially
desirable result. 86 But as this Recent Development has attempted
to demonstrate, the reverse may well be true. Admittedly, the
Cunningham approach avoids the imposition of a staggering financial
burden upon a single, unfortunate patient. However, this result has
been achieved through a method of risk allocation that lacks efficiency, fails to provide protection for all persons who are in need
of it, and leads to further increases in the cost of medical care.
Essentially, a greater diffusion of the costs attributable to the uncontrollable effects of proper medical care is needed; but, as pointed
out above, the tort law cannot achieve this goal. It is submitted,
therefore, that any decision concerning the allocation of risks for
unavoidable medical accidents would more appropriately be made
by a legislative body. Thorough committee investigations would
enable a legislature to gain a more complete understanding of all
the potential ramifications involved in spreading the costs of unavoidable medical accidents than the limited context of litigation will
allow. Therefore, a legislature would be in a much better position
to make practical and informed judgments about who should receive the needed protection, what products should be covered, and
what the financial limits of the protection should be.
It should be recognized that a legislative approach at the state
level would probably be impractical because, in order to achieve
nationwide loss-spreading, all fifty states would have to enact virtually identical statutes. However, several major proposals for an
extensive health care program have already been made at the federal
level.87 There appears to be no reason why a provision for the type
85. In fact, the outgrowth of Cunningham in Illinois has been precisely such a
lobbying effort. Noting that several states provide legislation to prohibit blood being
termed a "sale" (see note 41 supra), the Illinois Medical Society and the Illinois
Hospital Association both urged immediate enactment of statutes to counter the decision. .AMERICAN MEDICAL NEWs, Oct. 12, 1970, at 3, col. I. Several commentators have
opined that this reaction would be typical in any state that adopts the Cunningham
analysis. Zurgich Interview, supra note 64; AMERICAN MEDICAL NEWS, supra; The Wall
St. J., March 2, 1971, at 23, col. I (midwest ed.).
86. See 47 Ill. 2d at 457, 266 N.E.2d at 904, for the court's analysis of the economic
arguments made against the imposition of strict liability.
87. Six major proposals have been formulated.
Senator Edward Kennedy's proposal would provide federally financed comprehensive
health benefits, without cost sharing, for all United States citizens and residents, with
the present exclusion of adult dental care and with limitations placed upon the purchase of drugs, treatment in nursing homes, and mental health care. There would be
minimum cost to the lowest income earners, and up to $315 per year charged to those
earning in excess of $15,000. S. 3, 92d Cong., 1st Sess. (1971). See 117 CONG. R.Ec. S. 109
(daily ed. Jan. 25, 1971).
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of situation involved in Cunningham could not be included in any
proposal that is ultimately enacted. Such a legislative approach would
not necessarily be a perfect one, but it would be far superior to piecemeal judicial attempts to stretch established standards of responsibility beyond the range of their application and effectiveness.
President Nixon's plan would expand and almost entirely replace the present
medicaid program. Families on welfare and those in the lowest incomes would have
their premiums paid by the Government, while other working poor would pay on a
basis scaled upward as income rises. In addition, there would be possible coverage for
all persons with "catastrophic" illnesses, i.e., situations involving extremely costly treatments or incapacitations for relatively long durations. S. 1623, 92d Cong., 1st Sess. (1971).
See 117 CONG. REc. s. 1496, H. 77'! (daily ed. Feb. 18, 1971).
The Aetna Life 8: Casualty proposal, one receiving wide backing from the insurance
industry, would provide for the poor and uninsurable to elect minimum benefits
through private insurance, with the Government paying the premiums. This would include ambulatory and institutional care, with catastrophic medical expenses gradually
being extended to all, starting with the poor. H.R. 4349, 92d Cong., 1st Sess. (1971). See
117 CONG. REc. S. 1958 (daily ed. Feb. 25, 1971).
The American Medical Association-backed Fulton-Broyhill bill would be based upon
taxation credits and offered on a voluntary basis. Free coverage would be provided for
those persons paying $300 or less income tax, while others would be allowed a graded
scale of tax credits running from 98% ($301 income tax) to 10% (when taxes exceed
$1,300). Minimum benefits would include medical services, hospitalization up to sixty
days, and optional benefits including coverage for catastrophic illnesses. H.R. 4960-63,
92d Cong., 1st Sess. (1971). See 117 CONG. REc. S. 1957-58 {daily ed. Feb. 25, 1971).
Senator Jacob Javits' bill would expand medicare's hospitalization and medical
benefits. Coverage would eventually be provided for all with a minimal cost for the
lowest income earners and up to $495 annually for those earning in excess of $15,000.
S. 836, 92d Cong., 1st Sess. (1971). See 117 CONG. REc. S. 1959 (daily ed. Feb. 25, 1971).
Congresswoman Martha Griffiths' bill, supported by the AFL-CIO, calls for comprehensive health benefits to all persons residing in the United States for a year or
more, 11,ith minimal cost to the lowest income earners and a maximum annual cost
in any instance of $50 per individual and $100 per family. H.R. 22, 92d Cong., 1st Sess.
(1971). See 117 CONG. REc. H. 197 (daily ed. Jan. 26, 1971).
See generally National Health Insurance: The Next Attack on Medical Costs,
CHANGING TIMES, Jan. 1971, at 41; The Push Is on for Added Federal Health Aids,
U.S. NEWS 8: WORLD REP., Feb. 8, 1971, at 35-6.
The scope of this Recent Development does not include a comparison of the relative
merits of these programs. However, it is urged that the proposal finally adopted should
include provisions to insure adequate recompense for patients who contract hepatitis
unavoidably or who suffer any other deleterious effects from the proper administration
of modern medical therapy. Presently, because private insurance often furnishes only
partial coverage (see note 64 supra), it appears that the Kennedy and Griffiths proposals
would be the most amenable to this end.

